These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22378031)

  • 1. 1,2-disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents.
    Herrmann C; Salas PF; Patrick BO; de Kock C; Smith PJ; Adam MJ; Orvig C
    Dalton Trans; 2012 Jun; 41(21):6431-42. PubMed ID: 22378031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.
    Blackie MA; Beagley P; Croft SL; Kendrick H; Moss JR; Chibale K
    Bioorg Med Chem; 2007 Oct; 15(20):6510-6. PubMed ID: 17693090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates.
    Ferreira CL; Ewart CB; Barta CA; Little S; Yardley V; Martins C; Polishchuk E; Smith PJ; Moss JR; Merkel M; Adam MJ; Orvig C
    Inorg Chem; 2006 Oct; 45(20):8414-22. PubMed ID: 16999442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
    Biot C; Glorian G; Maciejewski LA; Brocard JS
    J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the role of the covalent linkage of ferrocene into a chloroquine template.
    Biot C; Daher W; Ndiaye CM; Melnyk P; Pradines B; Chavain N; Pellet A; Fraisse L; Pelinski L; Jarry C; Brocard J; Khalife J; Forfar-Bares I; Dive D
    J Med Chem; 2006 Jul; 49(15):4707-14. PubMed ID: 16854077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms.
    Salas PF; Herrmann C; Cawthray JF; Nimphius C; Kenkel A; Chen J; de Kock C; Smith PJ; Patrick BO; Adam MJ; Orvig C
    J Med Chem; 2013 Feb; 56(4):1596-613. PubMed ID: 23327489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.
    Rojas Ruiz FA; García-Sánchez RN; Estupiñan SV; Gómez-Barrio A; Torres Amado DF; Pérez-Solórzano BM; Nogal-Ruiz JJ; Martínez-Fernández AR; Kouznetsov VV
    Bioorg Med Chem; 2011 Aug; 19(15):4562-73. PubMed ID: 21723734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrocene-pyrimidine conjugates: Synthesis, electrochemistry, physicochemical properties and antiplasmodial activities.
    Chopra R; de Kock C; Smith P; Chibale K; Singh K
    Eur J Med Chem; 2015 Jul; 100():1-9. PubMed ID: 26057222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
    Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives.
    Mwande Maguene G; Lekana-Douki JB; Mouray E; Bousquet T; Grellier P; Pellegrini S; Toure Ndouo FS; Lebibi J; Pélinski L
    Eur J Med Chem; 2015 Jan; 90():519-25. PubMed ID: 25486423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antimalarial activity and cytotoxicity of 4-aminoquinoline-triazine conjugates.
    Manohar S; Khan SI; Rawat DS
    Bioorg Med Chem Lett; 2010 Jan; 20(1):322-5. PubMed ID: 19910192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II.
    Guillon J; Mouray E; Moreau S; Mullié C; Forfar I; Desplat V; Belisle-Fabre S; Pinaud N; Ravanello F; Le-Naour A; Léger JM; Gosmann G; Jarry C; Déléris G; Sonnet P; Grellier P
    Eur J Med Chem; 2011 Jun; 46(6):2310-26. PubMed ID: 21458112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.
    Musonda CC; Taylor D; Lehman J; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3901-5. PubMed ID: 15225694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of Novel Ferroquine and Phenylequine Analogues as Potential Antiplasmodial Agents.
    Jacobs L; de Kock C; de Villiers KA; Smith PJ; Smith VJ; van Otterlo WA; Blackie MA
    ChemMedChem; 2015 Dec; 10(12):2099-110. PubMed ID: 26447782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperazine-linked 4-aminoquinoline-chalcone/ferrocenyl-chalcone conjugates: Synthesis and antiplasmodial evaluation.
    Singh A; Rani A; Gut J; Rosenthal PJ; Kumar V
    Chem Biol Drug Des; 2017 Oct; 90(4):590-595. PubMed ID: 28332319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrocenyl and organic novobiocin derivatives: Synthesis and their in vitro biological activity.
    Mbaba M; Mabhula AN; Boel N; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
    J Inorg Biochem; 2017 Jul; 172():88-93. PubMed ID: 28441548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,4-diarylthiazole antiprion compounds as a novel structural class of antimalarial leads.
    Thompson MJ; Louth JC; Little SM; Chen B; Coldham I
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3644-7. PubMed ID: 21570837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine.
    Domarle O; Blampain G; Agnaniet H; Nzadiyabi T; Lebibi J; Brocard J; Maciejewski L; Biot C; Georges AJ; Millet P
    Antimicrob Agents Chemother; 1998 Mar; 42(3):540-4. PubMed ID: 9517929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
    Zishiri VK; Joshi MC; Hunter R; Chibale K; Smith PJ; Summers RL; Martin RE; Egan TJ
    J Med Chem; 2011 Oct; 54(19):6956-68. PubMed ID: 21875063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urea/oxalamide tethered β-lactam-7-chloroquinoline conjugates: synthesis and in vitro antimalarial evaluation.
    Singh P; Raj R; Singh P; Gut J; Rosenthal PJ; Kumar V
    Eur J Med Chem; 2014 Jan; 71():128-34. PubMed ID: 24287561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.